Lewis Tanya

Chief Dev. Op. Officer at Replimune Group, Inc. · on record since May 11, 2021
Vice President, Regulatory at VION PHARMACEUTICALS INC · on record since Dec 4, 2008
Director at DiaMedica Therapeutics Inc. · on record since Jun 3, 2026
Director at Replimune Group, Inc. · on record since Nov 3, 2020
EVP, Chief Reg. Affairs at Karyopharm Therapeutics Inc. · on record since Nov 5, 2019

Insider trading activity of Lewis Tanya

Transactions on record: 28; since Dec 12, 2008

Open-market buys: 0

Open-market sells: 6; $644.9K

Companies traded: 4; last filing Jun 3, 2026

Figures computed from official regulatory filings — methodology.

Companies where Lewis Tanya has traded

DiaMedica Therapeutics Inc.5 tx · Jun 3, 2026
Replimune Group, Inc.12 tx · $609.6K · Jun 15, 2023
Karyopharm Therapeutics Inc.10 tx · $35.3K · Mar 1, 2021
VION PHARMACEUTICALS INC1 tx · Dec 12, 2008

Track record of Lewis Tanya

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lewis Tanya

Co-insiders of Lewis Tanya

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
DiaMedica Therapeutics Inc.	Jun 3, 2026	AwardD	40,412	0.00 USD	$0	SEC
DiaMedica Therapeutics Inc.	Jun 3, 2025	AwardD	32,162	0.00 USD	$0	SEC
DiaMedica Therapeutics Inc.	Jun 3, 2024	AwardD	28,472	0.00 USD	$0	SEC
Replimune Group, Inc.	Jun 15, 2023	Sell	-12,043	24.10 USD	$290.2K	SEC
Replimune Group, Inc.	Jun 15, 2023	Sell	-817	23.45 USD	$19.2K	SEC
DiaMedica Therapeutics Inc.	Jun 2, 2023	AwardD	7,493	0.00 USD	$0	SEC
Replimune Group, Inc.	May 18, 2023	Sell	-12,207	18.05 USD	$220.3K	SEC
Replimune Group, Inc.	Apr 4, 2023	Award	40,000	0.00 USD	$0	SEC
Replimune Group, Inc.	Apr 4, 2023	AwardD	60,000	0.00 USD	$0	SEC
DiaMedica Therapeutics Inc.	Mar 6, 2023	AwardD	26,443	0.00 USD	$0	SEC
Replimune Group, Inc.	May 18, 2022	Sell	-5,473	14.59 USD	$79.9K	SEC
Replimune Group, Inc.	Apr 5, 2022	AwardD	78,750	0.00 USD	$0	SEC
Replimune Group, Inc.	Apr 5, 2022	Award	52,500	0.00 USD	$0	SEC
Replimune Group, Inc.	May 11, 2021	Award	73,333	0.00 USD	$0	SEC
Replimune Group, Inc.	May 11, 2021	AwardD	110,000	0.00 USD	$0	SEC
Replimune Group, Inc.	Apr 5, 2021	AwardD	16,500	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Mar 1, 2021	Award	22,013	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Mar 1, 2021	AwardD	59,968	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Feb 17, 2021	Sell	-2,046	15.52 USD	$31.8K	SEC
Karyopharm Therapeutics Inc.	Feb 9, 2021	ExerciseD	-5,650	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Feb 9, 2021	Exercise	5,650	—	—	SEC
Karyopharm Therapeutics Inc.	Nov 4, 2020	ExerciseD	-765	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Nov 4, 2020	Sell	-226	15.58 USD	$3.5K	SEC
Karyopharm Therapeutics Inc.	Nov 4, 2020	Exercise	765	—	—	SEC
Replimune Group, Inc.	Nov 3, 2020	AwardD	33,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
DiaMedica Therapeutics Inc.	Jun 3, 2026	AwardD	40,412	0.00 USD	$0	SEC
DiaMedica Therapeutics Inc.	Jun 3, 2025	AwardD	32,162	0.00 USD	$0	SEC
DiaMedica Therapeutics Inc.	Jun 3, 2024	AwardD	28,472	0.00 USD	$0	SEC
Replimune Group, Inc.	Jun 15, 2023	Sell	-12,043	24.10 USD	$290.2K	SEC
Replimune Group, Inc.	Jun 15, 2023	Sell	-817	23.45 USD	$19.2K	SEC
DiaMedica Therapeutics Inc.	Jun 2, 2023	AwardD	7,493	0.00 USD	$0	SEC
Replimune Group, Inc.	May 18, 2023	Sell	-12,207	18.05 USD	$220.3K	SEC
Replimune Group, Inc.	Apr 4, 2023	Award	40,000	0.00 USD	$0	SEC
Replimune Group, Inc.	Apr 4, 2023	AwardD	60,000	0.00 USD	$0	SEC
DiaMedica Therapeutics Inc.	Mar 6, 2023	AwardD	26,443	0.00 USD	$0	SEC
Replimune Group, Inc.	May 18, 2022	Sell	-5,473	14.59 USD	$79.9K	SEC
Replimune Group, Inc.	Apr 5, 2022	AwardD	78,750	0.00 USD	$0	SEC
Replimune Group, Inc.	Apr 5, 2022	Award	52,500	0.00 USD	$0	SEC
Replimune Group, Inc.	May 11, 2021	Award	73,333	0.00 USD	$0	SEC
Replimune Group, Inc.	May 11, 2021	AwardD	110,000	0.00 USD	$0	SEC
Replimune Group, Inc.	Apr 5, 2021	AwardD	16,500	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Mar 1, 2021	Award	22,013	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Mar 1, 2021	AwardD	59,968	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Feb 17, 2021	Sell	-2,046	15.52 USD	$31.8K	SEC
Karyopharm Therapeutics Inc.	Feb 9, 2021	ExerciseD	-5,650	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Feb 9, 2021	Exercise	5,650	—	—	SEC
Karyopharm Therapeutics Inc.	Nov 4, 2020	ExerciseD	-765	0.00 USD	$0	SEC
Karyopharm Therapeutics Inc.	Nov 4, 2020	Sell	-226	15.58 USD	$3.5K	SEC
Karyopharm Therapeutics Inc.	Nov 4, 2020	Exercise	765	—	—	SEC
Replimune Group, Inc.	Nov 3, 2020	AwardD	33,000	0.00 USD	$0	SEC